Search

Your search keyword '"ARTAN, Ayse Serra"' showing total 124 results
Start Over Author "ARTAN, Ayse Serra"
124 results on '"ARTAN, Ayse Serra"'

6. Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group

Author

Aydin, Zeki, Yilmaz, Murvet, Sipahioglu, Murat, Dervisoglu, Erkan, Aydemir, Nihal, Uzun, Sami, Istemihan, Zulal, Unsal, Oktay, Tatar, Erhan, Berktas, Haci Bayram, Ozdemir, Arzu, Sumnu, Abdullah, Kumru, Gizem, Cetinkaya, Hakki, Kazan, Sinan, Kocyigit, Ismail, Gokalp, Cenk, Hasbal, Baris, Artan, Ayse Serra, Ozelsancak, Ruya, Taymez, Dilek, Yadigar, Serap, Alagoz, Selma, Aslan, Bilal Burcak, Yaylaci, Selcuk, Jabrayilov, Jabrayil, Turgutalp, Kenan, Dursun, Belda, and Sahin, Garip

Published
2023
Full Text
View/download PDF

10. #1442 Retrospective evaluation of etiology, clinical and laboratory findings in patients diagnosed with secondary and genetic FSGS

Author

Yilmaz, Aysenur, primary, Suleymanova, Vafa, additional, Dirim, Ahmet Burak, additional, Kalayci, Tugba, additional, Artan, Ayse Serra, additional, Oto, Ozgur Akin, additional, Ozturk, Sukru, additional, Palanduz, Sukru, additional, Ozturk, Savas, additional, Turkmen, Aydin, additional, and Yazici, Halil, additional

Published
2024
Full Text
View/download PDF

18. Concurrent Cobalamin C and Plasminogen Deficiencies in a Patient with Chronic Thrombotic Microangiopathy

Author

Dirim, Ahmet Burak, primary, Safak, Seda, additional, Balci, Mehmet Cihan, additional, Ozyavuz, Pelin, additional, Garayeva, Nurane, additional, Tiryaki, Tarik Onur, additional, Oto, Ozgur Akin, additional, Ozluk, Yasemin, additional, Kilicaslan, Isin, additional, Solakoglu, Seyhun, additional, Artan, Ayse Serra, additional, Yazici, Halil, additional, Turkmen, Aydin, additional, and Ozturk, Savas, additional

Published
2023
Full Text
View/download PDF

19. Thromboembolic complications after COVID‐19 in kidney transplant recipients.

Author

Artan, Ayse Serra, Dirim, Ahmet Burak, Yavuzkilic, Halil, Demir, Erol, Oto, Ozgur Akin, Guller, Nurana, Safak, Seda, Yazici, Halil, and Turkmen, Aydin

Subjects
*KIDNEY transplantation, *THROMBOEMBOLISM, *KIDNEY transplant complications, *COVID-19, *VENOUS thrombosis, *HEART diseases
Abstract

Aim: Increased venous thrombosis and arterial embolism rates are observed in the general population during or after COVID‐19. Data regarding the kidney transplant population are scarce. In this study, we aim to investigate the thrombotic complications and risk factors associated with thrombotic complications in kidney transplant patients. Methods: This retrospective observational study included adult kidney transplant recipients diagnosed with COVID‐19 between March 2020 and June 2022. The endpoint was the occurrence of thromboembolic events. Results: Four hundred and sixty‐nine patients were followed for a median of 10.8 months after COVID‐19. Forty patients (8.5%) died. Thromboembolic complications developed in 51 (11.9%) of the surviving patients. Twenty‐four patients with thromboembolic events were receiving prophylactic anticoagulation before the event. The patients with mild, moderate, and severe COVID‐19 were 292, 129, and 48, respectively. Patients with moderate COVID‐19 had a significantly higher percentage of thromboembolic complications than patients with mild COVID‐19. Older age, prior heart disease, and moderate COVID‐19 were significantly associated with thromboembolic events. The incidence of thromboembolic events after COVID‐19 is 10.9 per 100 patient‐year. Conclusion: Thromboembolic complications were observed at increased rates in kidney transplant recipients after COVID‐19. Therefore, prospective and cohort studies for post‐COVID‐19 complications regarding the treatment modalities are urgently needed. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. #5012 THE EFFECT OF GLOMERULAR C3 DEPOSITION ON RENAL OUTCOME IN PATIENTS WITH MEMBRANOUS NEPHROPATHY: DATA OF THE TSN-GOLD STUDY

Author

Gursu, Meltem, primary, Cebeci, Egemen, additional, Turkmen, Aydin, additional, Dervisoglu, Erkan, additional, Sezen, Mehmet, additional, Turgutalp, Kenan, additional, Sahin, Gulizar Manga, additional, Trablus, Sinan, additional, Kutlay, Sim, additional, Uzun, Sami, additional, Üstündağ, Sedat, additional, Dursun, Belda, additional, Ayli, Deniz, additional, Tatar, Erhan, additional, Oztop, Kenan Evren, additional, Basturk, Taner, additional, Cevher, Simal Koksal, additional, Yilmaz, Zulfikar, additional, Tunca, Onur, additional, Sevinç, Mustafa, additional, Yadigar, Serap, additional, Duranay, Murat, additional, Arikan, Izzet Hakki, additional, Elcioglu, Omer Celal, additional, Karakan, Şebnem, additional, Turkmen, Kultigin, additional, Torun, Dilek, additional, Gungor, Ozkan, additional, Artan, Ayse Serra, additional, Ozturk, Savas, additional, Unsal, Abdülkadir, additional, and Seyahi, Nurhan, additional

Published
2023
Full Text
View/download PDF

24. A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients

Author

Caliskan, Yasar, primary, Mirioglu, Safak, additional, Dirim, Ahmet Burak, additional, Ozluk, Yasemin, additional, Yegit, Ozan, additional, Aksoy, Elif, additional, Safak, Seda, additional, Guller, Nurana, additional, Demir, Erol, additional, Artan, Ayse Serra, additional, Oto, Ozgur Akin, additional, Besisik, Sevgi, additional, Yazici, Halil, additional, Turkmen, Aydin, additional, and Lentine, Krista L., additional

Published
2022
Full Text
View/download PDF

25. Demographic, clinical and laboratory characteristics of adult-onset minimal change disease in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group

Author

Aydin, Zeki, primary, Yilmaz, Murvet, additional, Sipahioglu, Murat, additional, Dervisoglu, Erkan, additional, Aydemir, Nihal, additional, Uzun, Sami, additional, Istemihan, Zulal, additional, Unsal, Oktay, additional, Tatar, Erhan, additional, Berktas, Haci Bayram, additional, Ozdemir, Arzu, additional, Sumnu, Abdullah, additional, Kumru, Gizem, additional, Cetinkaya, Hakki, additional, Kazan, Sinan, additional, Kocyigit, Ismail, additional, Gokalp, Cenk, additional, Hasbal, Baris, additional, Artan, Ayse Serra, additional, Ozelsancak, Ruya, additional, Taymez, Dilek, additional, Yadigar, Serap, additional, Alagoz, Selma, additional, Aslan, Bilal Burcak, additional, Yaylaci, Selcuk, additional, Jabrayilov, Jabrayil, additional, Turgutalp, Kenan, additional, Dursun, Belda, additional, and Sahin, Garip, additional

Published
2022
Full Text
View/download PDF

26. Clinical and pathologic features of primary membranous nephropathy in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group

Author

Yildiz, Abdulmecit, primary, Ulu, Sena, additional, Oruc, Aysegul, additional, Ucar, Ali Riza, additional, Ozturk, Savas, additional, Alagoz, Selma, additional, Eren, Necmi, additional, Kocyigit, Ismail, additional, Koksal Cevher, Simal, additional, Haras, Ali Burak, additional, Sumnu, Abdullah, additional, Arinsoy, Turgay, additional, Sahin, Garip, additional, Suleymanlar, Gultekin, additional, Cavdar, Caner, additional, Kumru Sahin, Gizem, additional, Kurultak, Ilhan, additional, Unsal, Abdulkadir, additional, Sahin, Gulizar, additional, Kazan, Sinan, additional, Tatar, Erhan, additional, Dıkec, Mehmet, additional, Dursun, Belda, additional, Sayarlioglu, Hayriye, additional, Turkmen, Kultigin, additional, Artan, Ayse Serra, additional, Aktas, Nimet, additional, Yilmaz, Zulfikar, additional, Behlul, Ahmet, additional, Dheir, Hamad, additional, Kutlay, Sim, additional, and Seyahi, Nurhan, additional

Published
2022
Full Text
View/download PDF

27. A comparison of methods of plasmapheresis for the treatment of late antibody mediated rejection in kidney transplant recipients.

Author

Caliskan, Yasar, Mirioglu, Safak, Dirim, Ahmet Burak, Ozluk, Yasemin, Yegit, Ozan, Aksoy, Elif, Safak, Seda, Guller, Nurana, Demir, Erol, Artan, Ayse Serra, Oto, Ozgur Akin, Besisik, Sevgi, Yazici, Halil, Turkmen, Aydin, and Lentine, Krista L.

Subjects
KIDNEY transplantation, PLASMAPHERESIS, KIDNEY physiology, IMMUNOGLOBULINS, REGRESSION analysis
Abstract

Introduction: We compared the outcomes associated with plasma exchange (PE), double filtration plasmapheresis (DFPP), or immunoadsorption (IA) in the treatment of late antibody mediated rejection (AMR). Methods: Sixty‐nine kidney transplantation (KTx) recipients with late AMR were retrospectively categorized according to management with PE (n = 30), DFPP (n = 22) or IA (n = 17). Allograft loss was compared across treatment groups by Kaplan–Meier analysis and Cox regression. Results: Study groups were similar regarding age, sex, donor type, kidney function, donor specific antibodies, and post‐KTx follow‐up time. Five‐year graft survival trended higher with IA (70.6%) compared to PE (36.7%) and DFPP (27.3%) (p = 0.06). In multivariate Cox regression, baseline eGFR (HR per ml/min/1.73 m2 [95% CI]; 0.96 [0.94–0.99]), rituximab use (HR [95% CI]; 0.42 [0.21–0.84]), interstitial inflammation (i) (HR [95% CI]; 2.05 [1.13–3.69]), and transplant glomerulopathy (cg) (HR [95% CI]; 1.46 [1.13–1.87]) were associated with graft loss. Conclusion: These results motivate the need for continued assessment of rituximab and plasmapheresis in larger studies. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

28. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis

Author

Dirim, Ahmet Burak, primary, Demir, Erol, additional, Guller, Nurane, additional, Safak, Seda, additional, Artan, Ayse Serra, additional, Oto, Ozgur Akin, additional, Ozluk, Yasemin, additional, Ozturk, Savas, additional, Yazici, Halil, additional, Kalayoglu‐Besisik, Sevgi, additional, and Turkmen, Aydin, additional

Published
2022
Full Text
View/download PDF

29. Characteristics and Survival Results of Peritoneal Dialysis Patients Suffering from COVID-19 in Turkey: A Multicenter National Study

Author

Gursu, Meltem, primary, Ozturk, Savas, additional, Arici, Mustafa, additional, Sahin, Idris, additional, Gokcay Bek, Sibel, additional, Yilmaz, Murvet, additional, Koyuncu, Sumeyra, additional, Karahisar Sirali, Semahat, additional, Ural, Zeynep, additional, Dursun, Belda, additional, Yuksel, Enver, additional, Uzun, Sami, additional, Sipahi, Savaş, additional, Ahbap, Elbis, additional, Artan, Ayse Serra, additional, Altunoren, Orcun, additional, Tunca, Onur, additional, Ayar, Yavuz, additional, Gok Oguz, Ebru, additional, Yilmaz, Zulfukar, additional, Kahvecioglu, Serdar, additional, Asicioglu, Ebru, additional, Oruc, Aysegul, additional, Altiparmak, Mehmet Riza, additional, Aydin, Zeki, additional, Huddam, Bulent, additional, Dolarslan, Murside Esra, additional, Azak, Alper, additional, Bakırdogen, Serkan, additional, Yalcin, Ahmet Ugur, additional, Karadag, Serhat, additional, Ulu, Memnune Sena, additional, Gungor, Ozkan, additional, Ari Bakir, Elif, additional, Odabas, Ali Rıza, additional, Seyahi, Nurhan, additional, Yildiz, Alaattin, additional, and Ates, Kenan, additional

Published
2022
Full Text
View/download PDF

32. Oxidative stress and macrophage infiltration in IgA nephropathy

Author

Caliskan, Yasar, primary, Demir, Erol, additional, Karatay, Ecem, additional, Ozluk, Yasemin, additional, Mirioglu, Safak, additional, Dirim, Ahmet Burak, additional, Artan, Ayse Serra, additional, Usta Akgul, Sebahat, additional, Oto, Ozgur Akin, additional, Savran Oguz, Fatma, additional, Turkmen, Aydin, additional, Lentine, Krista L., additional, and Yazici, Halil, additional

Published
2021
Full Text
View/download PDF

33. Impact of the COVID-19 pandemic on interest in renal diseases

Author

Oto, Ozgur Akin, primary, Kardeş, Sinan, additional, Guller, Nurane, additional, Safak, Seda, additional, Dirim, Ahmet Burak, additional, Başhan, Yağmur, additional, Demir, Erol, additional, Artan, Ayse Serra, additional, Yazıcı, Halil, additional, and Turkmen, Aydın, additional

Published
2021
Full Text
View/download PDF

35. Minimal change disease following vaccination with CoronaVac

Author

Dirim, Ahmet Burak, primary, Safak, Seda, additional, Andac, Berk, additional, Garayeva, Nurana, additional, Demir, Erol, additional, Artan, Ayse Serra, additional, Ozluk, Yasemin, additional, Kilicaslan, Isin, additional, Oto, Ozgur Akin, additional, Ozturk, Savas, additional, and Yazici, Halil, additional

Published
2021
Full Text
View/download PDF

38. P0425MEMBRANOUS NEPHROPATHY IN TURKEY: TURKISH SOCIETY OF NEPHROLOGY GLOMERULER DISEASES (TSN-GOLD) DATABASE RESULTS

Author

Yildiz, Abdulmecit, primary, Ulu, Memnune Sena, primary, Oruc, Aysegul, primary, Ucar, Ali Riza, primary, Ozturk, Savas, primary, Alagoz, Selma, primary, Eren, Necmi, primary, Kocyigit, Ismail, primary, Koksal Cevher, Simal, primary, Haras, Ali Burak, primary, Sumnu, Abdullah, primary, Arinsoy, Turgay, primary, SAHIN, Garip, primary, Suleymanlar, Gultekin, primary, Cavdar, Caner, primary, Kumru Şahin, Gizem, primary, Kurultak, Ilhan, primary, Unsal, Abdulkadir, primary, Manga Sahin, Gulizar, primary, Kazan, Sinan, primary, Vatansever, Bulent, primary, Dikec, Mehmet, primary, Dursun, Belda, primary, Sayarlioglu, Hayriye, primary, Turkmen, Kultigin, primary, Artan, Ayse Serra, primary, Aktas, Nimet, primary, Yilmaz, Zulfikar, primary, Behlül, Ahmet, primary, Dheir, Hamad, primary, Kutlay, Sim, primary, and Seyahi, Nurhan, primary

Published
2020
Full Text
View/download PDF

40. Late diagnosis of a rare multisystemic genetic disorder: Transaldolase deficiency due to homozygous TALDO1 c.345dupA variant.

Author

Dirim, Ahmet Burak, Kalayci, Tugba, Safak, Seda, Garayeva Guller, Nurane, Oto, Ozgur Akin, Artan, Ayse Serra, Ozturk, Sukru, and Yazici, Halil

Subjects
DELAYED diagnosis, ATRIAL septal defects, GENETIC disorders, CIRRHOSIS of the liver, GENETIC testing, SODIUM bicarbonate, RENOVASCULAR hypertension
Abstract

This article discusses the case of a 42-year-old Caucasian woman who was diagnosed with a rare genetic disorder called transaldolase deficiency (TALDO-D). The patient presented with glycosuria, hypouricemia, mild kidney dysfunction, and a history of liver cirrhosis and atrial septal defect. The diagnosis was confirmed through genetic testing, which revealed a homozygous likely pathogenic variant in the TALDO1 gene. The patient was treated with N-acetylcysteine and sodium bicarbonate, and her liver and kidney function remained stable during the two-year follow-up. The article highlights the importance of considering TALDO-D in cases of multisystemic disorders with renal involvement. [Extracted from the article]

Published
2024
Full Text
View/download PDF

41. Evaluation of Kidney Function in Patients on Chemotherapy.

Author

Haziyev, Elgun, Gursu, Meltem, Seker, Mesut, Elcioglu, Omer Celal, Artan, Ayse Serra, Aliyev, Altay, Turk, Haci Mehmet, Demir, Tarik, Toprak, Ali, and Kazancioglu, Rumeyza Turan

Subjects
KIDNEY physiology, CHRONICALLY ill, GLOMERULAR filtration rate, CHRONIC kidney failure, CANCER chemotherapy, EPIDERMAL growth factor receptors
Abstract

Objective: We aimed to study whether long-term kidney function would be affected by different chemotherapy regimens in patients with malignancy. Methods: In this study, 500 cancer patients between the ages of 18 and 85 years were included. Estimated glomerular filtration rate (eGFR) calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula was used to evaluate renal function. Patients with eGFR less than 60 mL/min/1.73 m² before chemotherapy were excluded. Demographic and clinical data were recorded. Patients were divided into 4 groups according to the chemotherapy protocols: cisplatin-containing regimens, carboplatin-containing regimens, oxaliplatin-containing regimens, and platinum-free regimens. eGFR, urea, and creatinine values of 0th, 7th, 30th,and 180th days were recorded. Results: In 180 days of treatment, eGFR decreased in 69 (13.8%) patients, whereas it increased in 46 (9.2%) patients (P = .001) and remained unchanged in 385 patients (77%). The cisplatin group had lower eGFR at the 180th day compared to the carboplatin (P = .033), oxaliplatin (P = .007), and platinum-free groups (P < .001). The median eGFR at the 180th day was lower in the cisplatin group compared to baseline (P < .001), while eGFR levels were not changed in the carboplatin and oxaliplatin groups and were significantly increased in the platinum-free group (P = .004). Conclusion: Cisplatin-based treatment protocols were shown to worsen renal function during long-term follow-up. It is important to monitor kidney function closely for early intervention. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

42. SP148THE EFFECT OF BIOMARKERS AND OXFORD CLASSIFICATION ON PROGRESSION OF Ig A NEPHROPATHY

Author

Demir, Erol, primary, Artan, Ayse Serra, additional, Sunnetcioglu, Ecem, additional, Usta Akgul, Sebahat, additional, Temurhan, Sonay, additional, Kekik, Cigdem, additional, Catikkas, Nezahat Muge, additional, Caliskan, Yasar, additional, Yazici, Halil, additional, Savran, Fatma Oguz, additional, Turkmen, Aydin, additional, Kilicaslan, Isin, additional, Ozluk, Yasemin, additional, and Sever, Mehmet Sukru, additional

Published
2018
Full Text
View/download PDF

43. FP163GLOMERULAR DEPOSITION OF CD68 AND C4D: SIGNIFICANT MARKERS FOR PROGRESSION OF IGA NEPHROPATHY ?

Author

Demir, Erol, primary, Sunnetcioglu, Ecem, additional, Aksoy, Elif, additional, Temurhan, Sonay, additional, Akgül, Sebahat, additional, Artan, Ayse Serra, additional, Catikkas, Nezahat Muge, additional, Kekik, Cigdem, additional, Yazici, Halil, additional, Caliskan, Yasar, additional, Kilicaslan, Isin, additional, Savran, Fatma Oguz, additional, Turkmen, Aydin, additional, Ozluk, Yasemin, additional, and Sever, Mehmet Sukru, additional

Published
2018
Full Text
View/download PDF

44. Naturally nonanemic dialysis patients: Who are they?

Author

Yilmaz, Murvet, primary, Kircelli, Fatih, additional, Artan, Ayse Serra, additional, Oto, Ozgur, additional, Asci, Gulay, additional, Gunestepe, Kutay, additional, Basci, Ali, additional, Ok, Ercan, additional, and Sever, Mehmet Sukru, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results